Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Aptatek Biosciences closes financing to advance its PheCheck™ clinical program. The funding will support the clinical evaluation of the FDA Breakthrough-designated at-home monitoring system for PKU.
Round Type
Venture
PrincetonBiotechnologyHealth CareDescription
Aptatek Biosciences has successfully closed financing to support the advancement of its PheCheck™ clinical program. This program is focused on the clinical evaluation of their innovative at-home monitoring system for PKU. The system has received FDA Breakthrough designation, highlighting its importance in patient care. The funding will facilitate further development and evaluation.
Fundz sees it the moment Aptatek BioSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aptatek BioSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.